Skip to content
    Real-World Studies

    Straight-to-Test Telephone Triage Pathway Streamlines Urgent Head and Neck Cancer Referrals

    Kiakou et alCureus

    In response to high referral volumes and resource constraints, a regional Head and Neck Cancer service at Broomfield Hospital (Mid and South Essex NHS Foundation Trust) evaluated a telephone triage and 'straight-to-test' (STT) model for urgent two-week wait (2WW) referrals. In this pathway, patients underwent initial telephone triage by an Ear, Nose, and Throat (ENT) clinician and were directed straight to cross-sectional or appropriate diagnostic imaging, bypassing initial in-person clinical consultations.
    In a retrospective observational pilot study of 495 2WW referrals, 104 patients (21.0%) were discharged directly following initial telephone consultation, while 94 patients (19.0%) were routed through the STT imaging pathway. Among the STT cohort (mean age 56.2 years; 42.6% male, 57.4% female), malignancy was detected in 14.9% (n=14), encompassing squamous cell carcinoma, well-differentiated thyroid carcinoma, lymphoproliferative disease, and metastatic malignancy. Benign conditions were identified in 40.4% (n=38) of patients. Following imaging, 52.1% (n=49) of patients were discharged without needing further consultations. Cross-sectional CT/MRI was performed significantly more often in patients with malignant vs. non-malignant findings (50.0% vs. 12.5%, p=0.003). The findings demonstrate that an STT telephone triage model effectively identifies head and neck malignancies while reducing unnecessary outpatient visits in high-volume settings.

    Key Takeaways

    • The telephone triage and straight-to-test pathway achieved a 14.9% malignancy detection rate among high-risk urgent two-week wait head and neck referrals.
    • Following diagnostic imaging, 52.1% of patients managed through the straight-to-test model were discharged without requiring subsequent face-to-face clinical consultations.
    • Cross-sectional imaging (CT/MRI) was utilized significantly more frequently in patients diagnosed with malignant pathology compared to those with non-malignant findings (50.0% vs. 12.5%, p=0.003).